These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 32564271)

  • 1. "NMDA receptor spectrum disorder" in the differential diagnosis of demyelinating disorders of the CNS: optic neuritis and myelitis.
    Etemadifar M; Abhari AP; Sabeti F; Ganjalikhani-Hakemi M; Salari M; Hashemi F; Aghababaee A; Khorvash R; Khayati MH; Nouri H
    Neurol Sci; 2021 Jan; 42(1):151-157. PubMed ID: 32564271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system].
    Yang Y; Wu WP; Huang DH; Wu L
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying optic neuritis and transverse myelitis using administrative data.
    Marrie RA; Ekuma O; Wijnands JMA; Kingwell E; Zhu F; Zhao Y; Fisk JD; Evans C; Tremlett H
    Mult Scler Relat Disord; 2018 Oct; 25():258-264. PubMed ID: 30144696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-NMDAR encephalitis associated with relapsing optic neuritis: a case report and differential diagnosis].
    Belova AN; Grygorieva VN; Rasteryaeva MV; Ruina EA; Belova EM; Solovieva VS; Boyko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(10. Vyp. 2):137-146. PubMed ID: 31934999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optic neuritis associated with anti-NMDA receptor antibody in the remission phase of anti-NMDA receptor encephalitis.
    Liu X; Giri M; Ling W; Li T
    Neurol India; 2020; 68(2):474-477. PubMed ID: 32415028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-NMDAR encephalitis associated with relapsing optic neuritis].
    Belova AN; Grygorieva VN; Rasteryaeva MV; Ruina EA; Belova EM; Solovieva VS; Boyko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(6):105-113. PubMed ID: 32678556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-MOG antibodies plead against MS diagnosis in an Acquired Demyelinating Syndromes cohort.
    Ketelslegers IA; Van Pelt DE; Bryde S; Neuteboom RF; Catsman-Berrevoets CE; Hamann D; Hintzen RQ
    Mult Scler; 2015 Oct; 21(12):1513-20. PubMed ID: 25662345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-NMDA receptor antibody encephalitis with recurrent optic neuritis and epilepsy].
    Motoyama R; Shiraishi K; Tanaka K; Kinoshita M; Tanaka M
    Rinsho Shinkeigaku; 2010 Aug; 50(8):585-8. PubMed ID: 20803970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of recurrent MOG antibody positive bilateral optic neuritis and anti-NMDAR encephalitis: Different biological evolution of the two associated antibodies.
    Rojc B; Podnar B; Graus F
    J Neuroimmunol; 2019 Mar; 328():86-88. PubMed ID: 30599296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare concurrence: Antibodies against Myelin Oligodendrocyte Glycoprotein and N-methyl-d-aspartate receptor in a child.
    Sarigecili E; Cobanogullari MD; Komur M; Okuyaz C
    Mult Scler Relat Disord; 2019 Feb; 28():101-103. PubMed ID: 30590238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of aquaporin-4 antibodies for patients with CNS inflammatory demyelinating diseases other than typical MS in Lithuania.
    Sakalauskaitė-Juodeikienė E; Armalienė G; Kizlaitienė R; Bagdonaitė L; Giedraitienė N; Mickevičienė D; Rastenytė D; Kaubrys G; Jatužis D
    Brain Behav; 2018 Nov; 8(11):e01129. PubMed ID: 30284401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The limited demyelinating diseases: the voyage of optic neuritis and transverse myelitis to multiple sclerosis and neuromyelitis.
    Idiman E; Ozakbaş S
    Expert Rev Neurother; 2011 Mar; 11(3):451-62. PubMed ID: 21375450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aquaporin 4 antibody [NMO Ab] status in patients with severe optic neuritis in India.
    Ambika S; Balasubramanian M; Theresa L; Veeraputhiran A; Arjundas D
    Int Ophthalmol; 2015 Dec; 35(6):801-6. PubMed ID: 25682013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Myelin Oligodendrocyte Glycoprotein Antibody Associated With Gray Matter Predominant Transverse Myelitis Mimicking Acute Flaccid Myelitis: A Presentation of Two Cases.
    Wang C; Narayan R; Greenberg B
    Pediatr Neurol; 2018 Sep; 86():42-45. PubMed ID: 30077551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromyelitis optica spectrum disorders in South of Tunisia: A rare entity with low seroprevalence of anti-aquaporin 4 autoantibodies.
    Mejdoub S; Feki S; Dammak M; Farhat N; Hdiji O; Boukthir S; Hachicha H; Mhiri C; Masmoudi H
    Rev Neurol (Paris); 2020 May; 176(4):261-267. PubMed ID: 31668529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis.
    Oliveira LM; Apóstolos-Pereira SL; Pitombeira MS; Bruel Torretta PH; Callegaro D; Sato DK
    Mult Scler; 2019 Dec; 25(14):1907-1914. PubMed ID: 30417715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A case of anti-myelin oligodendrocyte glycoprotein (MOG) and anti-N-methyl-D-aspartate (NMDA) receptor antibody-positive encephalitis with optic neuritis].
    Nagata S; Nishimura Y; Mitsuo K
    Rinsho Shinkeigaku; 2018 Oct; 58(10):636-641. PubMed ID: 30270341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical spectrum of anti-MOG associated acquired demyelinating disorders: Three case-reports.
    Bellinvia A; Pastò L; Razzolini L; Fratangelo R; Prestipino E; Fonderico M; Tudisco L; Amato MP
    Mult Scler Relat Disord; 2019 Aug; 33():51-54. PubMed ID: 31152967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overlapping autoimmune syndrome: A case of concomitant anti-NMDAR encephalitis and myelin oligodendrocyte glycoprotein (MOG) antibody disease.
    Pérez CA; Agyei P; Gogia B; Harrison R; Samudralwar R
    J Neuroimmunol; 2020 Feb; 339():577124. PubMed ID: 31837635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atypical MOG antibody disease presenting with typical multiple sclerosis lesions.
    Dolbec K; Chalkley J; Sudhakar P
    Mult Scler Relat Disord; 2020 Sep; 44():102342. PubMed ID: 32615531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.